Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fournel

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Occupational Medicine (Oxford, England)|May 4, 2019
Implementation of a self-administered questionnaire to detect lung carcinogensC Pelissier, J Kalecinski, S Brochaye, et al.
Oncology|March 1, 1996
Bronchial carcinoids. A review of 22 casesM Froudarakis, P Fournel, G Burgard, et al.
Respiration; International Review of Thoracic Diseases|July 21, 2001
Invasive thymoma: a clinical study of 23 casesM E Froudarakis, O Tiffet, P Fournel, et al.
Acta Oncologica (Stockholm, Sweden)|March 26, 2019
Obesity and chemotherapy administration: between empiric and mathematic method reviewW Bouleftour, B Mery, E Chanal, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1995
Limbic encephalitis and immunological perturbations in two patients with thymomaJ C Antoine, J Honnorat, C T Anterion, et al.
Revue Des Maladies Respiratoires|October 22, 2022
[Management of EGFR mutated non-small cell lung carcinoma patients]M-P Perquis, C Tissot, W Bouleftour, et al.
Revue De Pneumologie Clinique|January 1, 1986
[Difficult diagnosis of a rapidly developing post-traumatic tumor of the thymus region. Encysted hematoma or intracystic hemorrhage?]J M Vergnon, J Cuilleret, P Fournel, et al.
Lung Cancer (Amsterdam, Netherlands)|January 26, 2023
Loss of smell in lung cancer patients undergoing chemotherapy: Prevalence and relationship with food habit changesK Drareni, A Dougkas, A Giboreau, et al.
Chest|April 29, 1998
Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancerM E Froudarakis, G Sourvinos, P Fournel, et al.
Bulletin Du Cancer|January 1, 1993
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers]P J Souquet, P Fournel, M Jorda, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Occupational Medicine (Oxford, England)|May 4, 2019
Implementation of a self-administered questionnaire to detect lung carcinogensC Pelissier, J Kalecinski, S Brochaye, et al.
Oncology|March 1, 1996
Bronchial carcinoids. A review of 22 casesM Froudarakis, P Fournel, G Burgard, et al.
Respiration; International Review of Thoracic Diseases|July 21, 2001
Invasive thymoma: a clinical study of 23 casesM E Froudarakis, O Tiffet, P Fournel, et al.
Acta Oncologica (Stockholm, Sweden)|March 26, 2019
Obesity and chemotherapy administration: between empiric and mathematic method reviewW Bouleftour, B Mery, E Chanal, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1995
Limbic encephalitis and immunological perturbations in two patients with thymomaJ C Antoine, J Honnorat, C T Anterion, et al.
Revue Des Maladies Respiratoires|October 22, 2022
[Management of EGFR mutated non-small cell lung carcinoma patients]M-P Perquis, C Tissot, W Bouleftour, et al.
Revue De Pneumologie Clinique|January 1, 1986
[Difficult diagnosis of a rapidly developing post-traumatic tumor of the thymus region. Encysted hematoma or intracystic hemorrhage?]J M Vergnon, J Cuilleret, P Fournel, et al.
Lung Cancer (Amsterdam, Netherlands)|January 26, 2023
Loss of smell in lung cancer patients undergoing chemotherapy: Prevalence and relationship with food habit changesK Drareni, A Dougkas, A Giboreau, et al.
Chest|April 29, 1998
Microsatellite instability and loss of heterozygosity at chromosomes 9 and 17 in non-small cell lung cancerM E Froudarakis, G Sourvinos, P Fournel, et al.
Bulletin Du Cancer|January 1, 1993
[Results of a combination of platinum-vindesin-ametycin-bleomycin (CEMB) in the treatment of stage IV non-small-cell lung cancers]P J Souquet, P Fournel, M Jorda, et al.
Pageof 9